XML 28 R19.htm IDEA: XBRL DOCUMENT v3.19.2
CB Oncology Partners (Tables)
 6 Months Ended
Jun. 30, 2019
CB Oncology Partners LLC [Member]  
Schedule of Equity Method Investments [Line Items]  
Equity Method Investment Summarized Financial Information
The following table presents the summarized financial information of CBOP

CBOP Condensed Income Statement Information

  
Six Months Ended
June 30,
 
  
2019
  
2018
 
       
Patient revenue
 
$
748,000
  
$
488,000
 
         
Net loss
 
$
(573,000
)
 
$
(501,000
)
         
USNC's equity in loss in CBOP
 
$
(139,000
)
 
$
(121,000
)

  
Three Months Ended
June 30,
 
  
2019
  
2018
 
       
Patient revenue
 
$
335,000
  
$
376,000
 
         
Net loss
 
$
(340,000
)
 
$
(160,000
)
         
USNC's equity in loss in CBOP
 
$
(83,000
)
 
$
(38,000
)

CBOP Condensed Balance Sheet Information

  
June 30,
2019
  
December 31,
2018
 
       
       
Current assets
 
$
255,000
  
$
140,000
 
         
Noncurrent assets
  
-
   
-
 
         
Total assets
 
$
255,000
  
$
140,000
 
         
Current liabilities
 
$
2,306,000
  
$
1,618,000
 
         
Noncurrent liabilities
  
-
   
-
 
         
Deficit
  
(2,051,000
)
  
(1,478,000
)
         
Total liabilities and equity
 
$
255,000
  
$
140,000